Early add-on Vildagliptin in Patients With Type 2 Diabetes Inadequately Controlled by Metformin
Status:
Completed
Trial end date:
2015-10-22
Target enrollment:
Participant gender:
Summary
The purpose of this study was to observe change of HbA1c over time from baseline to month 12.
The ultimate goal of this study was to provide a local reference value to the physicians &
patients in the future when they consider initiating Vildagliptin and taking balance between
efficacy, compliance, risk factors, convenience and medication cost.